Autophagy is a catabolic process required for the maintenance of cardiac health. Insulin and insulin-like growth factor 1 (IGF-1) are potent inhibitors of autophagy and as such, one would predict that autophagy will be increased in the insulin-resistant/diabetic heart. However, autophagy is rather decreased in the hearts of diabetic/insulin-resistant mice. The aim of this study is to determine the contribution of IGF-1 receptor signaling to autophagy suppression in insulin receptor (IR)-deficient hearts.
Results:
Absence of IRs in the heart was associated with reduced autophagic flux, and further inhibition of autophagosome clearance reduced survival, impaired contractile function, and enhanced myocyte loss. Contrary to the in vivo setting, isolated cardiomyocytes from IR-deficient hearts exhibited unrestrained autophagy in the absence of insulin, whereas addition of insulin was able to suppress autophagy. To investigate the mechanisms involved in the maintenance of the responsiveness to insulin in IR-deficient hearts, we generated mice lacking both IRs and one copy of the IGF-1 receptor (IGF-1R) in cardiac cells and showed that these mice had increased autophagy.
Innovation and Conclusion:
This study unveils a new mechanism by which IR-deficient hearts can still respond to insulin to suppress autophagy, in part, through activation of IGF-1R signaling. This is a highly significant observation because it is the first to show that systemic hyperinsulinemia can suppress autophagy in IR-deficient hearts through IGF-1R signaling. Antioxid. Redox Signal. 31, 444–457.
Get full access to this article
View all access options for this article.
References
1.
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387: 1513–1530, 2016.
2.
BoucherJ, CharalambousM, ZarseK, MoriMA, KleinriddersA, RistowM, Ferguson-SmithAC, KahnCR. Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes. Proc Natl Acad Sci U S A, 111: 14512–14517, 2014.
3.
BoudinaS, SenaS, TheobaldH, ShengX, WrightJJ, HuXX, AzizS, JohnsonJI, BuggerH, ZahaVG, AbelED. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes, 56: 2457–2466, 2007.
4.
ColomboL, BaldariG, LogiG, LusiniA. [The use of levulose in resuscitation]. Acta Anaesthesiol 20: Suppl, 2:79–90, 1969.
5.
CookSA, Varela-CarverA, MongilloM, KleinertC, KhanMT, LeccisottiL, StricklandN, MatsuiT, DasS, RosenzweigA, PunjabiP, CamiciPG. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J, 31: 100–111, 2010.
6.
FruddK, BurgoyneT, BurgoyneJR. Oxidation of Atg3 and Atg7 mediates inhibition of autophagy. Nat Commun, 9: 95, 2018.
7.
FujitaN, ItohT, OmoriH, FukudaM, NodaT, YoshimoriT. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell, 19: 2092–2100, 2008.
8.
GodarRJ, MaX, LiuH, MurphyJT, WeinheimerCJ, KovacsA, CrosbySD, SaftigP, DiwanA. Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury. Autophagy, 11: 1537–1560, 2015.
9.
GrundySM, BenjaminIJ, BurkeGL, ChaitA, EckelRH, HowardBV, MitchW, SmithSCJr., SowersJR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 100: 1134–1146, 1999.
10.
GubbiottiMA, SeifertE, RodeckU, HoekJB, IozzoRV. Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin. J Biol Chem, 293: 16940–16950, 2018.
11.
HanYH, BuffoloM, PiresKM, PeiS, SchererPE, BoudinaS. Adipocyte-specific deletion of manganese superoxide dismutase protects from diet-induced obesity through increased mitochondrial uncoupling and biogenesis. Diabetes, 65: 2639–2651, 2016.
12.
HeC, KlionskyDJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet, 43: 67–93, 2009.
13.
HeC, ZhuH, LiH, ZouMH, XieZ. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes, 62: 1270–1281, 2013.
14.
HsuHC, ChenCY, LeeBC, ChenMF. High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagy. Eur J Nutr, 55: 2245–2254, 2016.
15.
HuynhK, McMullenJR, JuliusTL, TanJW, LoveJE, CemerlangN, KiriazisH, DuXJ, RitchieRH. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes, 59: 1512–1520, 2010.
16.
IkedaH, ShiojimaI, OzasaY, YoshidaM, HolzenbergerM, KahnCR, WalshK, IgarashiT, AbelED, KomuroI. Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. J Mol Cell Cardiol, 47: 664–675, 2009.
17.
Iwai-KanaiE, YuanH, HuangC, SayenMR, Perry-GarzaCN, KimL, GottliebRA. A method to measure cardiac autophagic flux in vivo. Autophagy, 4: 322–329, 2008.
KanamoriH, TakemuraG, GotoK, TsujimotoA, MikamiA, OginoA, WatanabeT, MorishitaK, OkadaH, KawasakiM, SeishimaM, MinatoguchiS. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Autophagy, 11: 1146–1160, 2015.
20.
KimJ, WendeAR, SenaS, TheobaldHA, SotoJ, SloanC, WaymentBE, LitwinSE, HolzenbergerM, LeRoithD, AbelED. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol, 22: 2531–2543, 2008.
21.
KobayashiS, XuX, ChenK, LiangQ. Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury. Autophagy, 8: 577–592, 2012.
22.
LancelS, MontaigneD, MarechalX, MarciniakC, HassounSM, DecosterB, BallotC, BlazejewskiC, CorseauxD, LescureB, MotterliniR, NeviereR. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One, 7: e41836, 2012.
23.
LarbigR, TorresN, BridgeJH, GoldhaberJI, PhilipsonKD. Activation of reverse Na+-Ca2+ exchange by the Na+ current augments the cardiac Ca2+ transient: evidence from NCX knockout mice. J Physiol, 588: 3267–3276, 2010.
24.
LaustsenPG, RussellSJ, CuiL, Entingh-PearsallA, HolzenbergerM, LiaoR, KahnCR. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol, 27: 1649–1664, 2007.
LiZL, WoollardJR, EbrahimiB, CraneJA, JordanKL, LermanA, WangSM, LermanLO. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol, 32: 1132–1141, 2012.
27.
LumJJ, BauerDE, KongM, HarrisMH, LiC, LindstenT, ThompsonCB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 120: 237–248, 2005.
28.
MaK, FuW, TangM, ZhangC, HouT, LiR, LuX, WangY, ZhouJ, LiX, ZhangL, WangL, ZhaoY, ZhuWG. PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment. Autophagy, 13: 579–591, 2017.
MellorKM, BellJR, YoungMJ, RitchieRH, DelbridgeLM. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol, 50: 1035–1043, 2011.
33.
MenkeA, CasagrandeS, GeissL, CowieCC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988–2012. JAMA, 314: 1021–1029, 2015.
34.
MunasinghePE, RiuF, DixitP, EdamatsuM, SaxenaP, HamerNS, GalvinIF, BuntonRW, LequeuxS, JonesG, LambertsRR, EmanueliC, MadedduP, KatareR. Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway. Int J Cardiol, 202: 13–20, 2016.
35.
NaitoT, KumaA, MizushimaN. Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle. J Biol Chem, 288: 21074–21081, 2013.
36.
NakaiA, YamaguchiO, TakedaT, HiguchiY, HikosoS, TaniikeM, OmiyaS, MizoteI, MatsumuraY, AsahiM, NishidaK, HoriM, MizushimaN, OtsuK. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med, 13: 619–624, 2007.
Paula-GomesS, GonçalvesDAP, BavieraAM, ZanonNM, NavegantesLCC, KettelhutIC. Insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes through AKT/FOXO signaling. Horm Metab Res, 45: 849–855, 2013.
39.
PiresKM, BuffoloM, SchaafC, David SymonsJ, CoxJ, AbelED, SelzmanCH, BoudinaS. Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic mice. J Mol Cell Cardiol, 113: 39–50, 2017.
SciarrettaS, ZhaiP, ShaoD, MaejimaY, RobbinsJ, VolpeM, CondorelliG, SadoshimaJ. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation, 125: 1134–1146, 2012.
42.
ShcherbakovAS. [Special prosthoelontic methods for patients with microstomia]. Stomatologiia (Mosk), 48: 78–80, 1969.
43.
StamlerJ, VaccaroO, NeatonJD, WentworthD. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16: 434–444, 1993.
XieZ, LauK, EbyB, LozanoP, HeC, PenningtonB, LiH, RathiS, DongY, TianR, KemD, ZouMH. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes, 60: 1770–1778, 2011.
46.
XuX, HuaY, NairS, ZhangY, RenJ. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J Mol Cell Biol, 5: 61–63, 2013.
47.
XuX, KobayashiS, ChenK, TimmD, VoldenP, HuangY, GulickJ, YueZ, RobbinsJ, EpsteinPN, LiangQ. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J Biol Chem, 288: 18077–18092, 2013.
48.
XuX, RenJ. Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int J Obes (Lond), 39: 387–396, 2015.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
